Upexi Inc
UPXI8.150USD
+0.670+8.96%
Handelsschluss 07/21, 16:00（ET）Kurse um 15 Minuten verzögert
11.66MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Upexi Inc Unternehmen
Upexi, Inc. is a brand owner specialized in the development, manufacturing and distribution of consumer products. The Company focuses on direct-to-consumer and Amazon brands. The Company’s brands include LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs, and Upexi Distribution. LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements. Gumi Labs manufactures gummies and other products supporting its health and wellness products, including those products manufactured with hemp ingredients. Upexi Distribution manages the warehousing and logistic needs of the Company and provides storage, consolidation, assembly, Amazon preparation, distribution and fulfilment services to its brands and its manufacturing operation.
Unternehmensinformationen
BörsenkürzelUPXI
Name des UnternehmensUpexi Inc
IPO-datumJun 24, 2021
Gegründet am2018
CEO- -
Anzahl der mitarbeiter64
WertpapierartOrdinary Share
GeschäftsjahresendeJun 24
Addresse3030 Rocky Point Drive
StadtTAMPA
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl33607
Telefon17013535425
Websitehttps://upexi.com/
BörsenkürzelUPXI
IPO-datumJun 24, 2021
Gegründet am2018
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
884.32K
+484.01%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
365.13K
+194.70%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
159.14K
+941.62%
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
884.32K
+484.01%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
365.13K
+194.70%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
159.14K
+941.62%
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q2
FY2025Q1
FY2024Q1
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Internally manufactured
2.51M
62.68%
Contract manufactured
834.86K
20.84%
Purchased as finished goods
659.80K
16.47%
Nach RegionUSD
Name
Umsatz
Anteil
United States of America
3.95M
98.66%
Other
53.69K
1.34%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Internally manufactured
2.51M
62.68%
Contract manufactured
834.86K
20.84%
Purchased as finished goods
659.80K
16.47%
Aktionärsstatistik
Aktualisiert: Fri, Jul 18
Aktualisiert: Fri, Jul 18
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Attestor Capital LLP
6.79%
GSR Growth Investments LP
4.58%
Novogratz (Michael E)
4.35%
Kathmere Capital Management
4.35%
Marshall (Allan)
1.76%
Other
78.17%
Aktionäre
Aktionäre
Anteil
Attestor Capital LLP
6.79%
GSR Growth Investments LP
4.58%
Novogratz (Michael E)
4.35%
Kathmere Capital Management
4.35%
Marshall (Allan)
1.76%
Other
78.17%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
8.02%
Hedge Fund
6.79%
Corporation
4.58%
Investment Advisor
4.38%
Investment Advisor/Hedge Fund
0.04%
Other
76.19%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
42
6.37M
16.79%
+6.01M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
2023Q3
40
369.15K
37.28%
-46.01K
2023Q2
44
368.80K
38.85%
-28.58K
2023Q1
40
400.82K
45.14%
-64.50K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
GSR Growth Investments LP
2.31M
6.08%
+2.31M
--
Apr 24, 2025
Novogratz (Michael E)
2.19M
5.78%
+2.19M
--
Apr 24, 2025
Marshall (Allan)
884.32K
2.33%
+732.89K
+484.01%
Apr 17, 2025
Rudick (Brian Benjamin)
438.60K
1.16%
+438.60K
--
May 23, 2025
Salkind (Gene)
365.13K
0.96%
+241.23K
+194.70%
Apr 17, 2025
Norstrud (Andrew J)
159.14K
0.42%
+143.86K
+941.62%
Apr 17, 2025
BMO Nesbitt Burns Inc.
10.01K
0.03%
--
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sun, Jul 6
Aktualisiert: Sun, Jul 6
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Datum
Art
Verhältnis
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
